8-K/A

FORM 8-K/A

Company: KalVista Pharmaceuticals, Inc.
Filed: December 20, 2016
Period of Report: November 21, 2016
Accession Number: 0001193125-16-797797

View Document ↗ View on SEC.gov ↗